HOME Top Market Reports In Vivo Toxicology Market by Product (Instruments, Consumables (Animal models, Reagents & Kits)), Testing type (Chronic, Sub-chronic), Toxicity Endpoints (Immunotoxicity, Systemic, DART), Testing Facility (Outsourced, In-house) - Global Forecast to 2022

In Vivo Toxicology Market by Product (Instruments, Consumables (Animal models, Reagents & Kits)), Testing type (Chronic, Sub-chronic), Toxicity Endpoints (Immunotoxicity, Systemic, DART), Testing Facility (Outsourced, In-house) - Global Forecast to 2022

By: marketsandmarkets.com
Publishing Date: February 2018
Report Code: BT 6000

 

  Speak to Analyst Enquiry Before Buying Webinar
purchase report
download pdf  request for customisation


The global in vivo toxicology market was valued at USD 4.15 Billion in 2016 and is expected to grow at a CAGR of 6.9% during the forecast period to reach to USD 6.14 Billion by 2022. The base year considered for the study is 2016 and the forecast for the market size is provided for the period between 2017 and 2022. Factors such as increasing pharmaceutical R&D activities, mandatory government regulations for animal testing, innovations in animal models, and the development of exclusive in vivo toxicology tests are driving the growth of the global market.

Objectives of the Study

  • To define, describe, and forecast the global market by product, testing type, toxicity endpoint, testing facility, and region
  • To provide detailed information regarding the major factors influencing the growth of the global market (drivers, restraints, opportunities, and challenges)
  • To strategically analyze micromarkets with respect to individual growth trends, future prospects, and contributions to the overall market
  • To analyze the opportunities in the market for stakeholders and provide details of the competitive landscape for market leaders
  • To forecast the size of market segments with respect to five main regions, namely, North America, Europe, Asia Pacific, Latin America, and Middle East Africa
  • To profile key players and comprehensively analyze their core competencies in terms of key market developments, product portfolios, and financials
  • To track and analyze competitive developments such as product launches & services, collaborations, partnerships, and agreements, acquisitions & mergers, expansions, and other developments in the global market

Research Methodology

Top-down and bottom-up approaches were used to validate the size of the in vivo toxicology market and estimate the size of other dependent submarkets. Various secondary sources such as Food and Drug Administration (FDA), United States Environmental Protection Agency (USEPA), National Institute of Environmental Health Sciences (NIEHS), Association for Assessment and Accreditation of Laboratory Animal Care (AAALAC), Registration, Evaluation, Authorisation and Restriction of Chemicals (REACH), Federation of European Toxicologists and European Societies of Toxicology (EUROTOX), Institute of Laboratory Animal Sciences (ILAS), National Council for the Control of Animal Experimentation (CONCEA), Organisation for Economic Co-operation and Development (OECD), World Bank, Academic Journals, Company Websites, expert interviews, annual reports, SEC filings, investor presentations, and MarketsandMarkets Analysishave been used to identify and collect information useful for the study of this market. Primary sources such as experts from both supply and demand sides have been interviewed to obtain and validate information as well as to assess dynamics of this market. The breakdown of profiles of primaries is shown in the figure below:

In Vivo Toxicology Market

To know about the assumptions considered for the study, download the pdf brochure

Target Audience:

  • Pharmaceutical and biotechnology companies
  • Medical devices manufacturers
  • Clinical research organizations
  • Academic & research institutes
  • Market research and consulting firms

Scope of the Report:

The research report categorizes the global market into the following segments and subsegments:

In Vivo Toxicology Market, by Product

  • Consumables
    • Reagents & Kits
    • Animal Models
  • Mice Models
  • Rat Models
  • Other Animal Models
  • Instruments

In Vivo Toxicology Market, by Testing Type

  • Chronic Toxicity Testing
  • Sub-chronic Toxicity Testing
  • Sub-acute Toxicity Testing
  • Acute Toxicity Testing

In Vivo Toxicology Market, by Toxicity Endpoint

  • Immunotoxicity
  • Systemic Toxicity
  • Carcinogenicity
  • Genotoxicity
  • Developmental and Reproductive Toxicity (DART)
  • Other Toxicity Endpoints

In Vivo Toxicology Market, by Region

  • North America
    • US
    • Canada
  • Europe
    • Germany
    • UK
    • France
    • Rest of Europe
  • Asia Pacific (APAC)
    • Japan
    • China
    • India
    • Rest of APAC
  • Latin America
  • Middle East & Africa

Available Customizations

With the given market data, MarketsandMarkets offers customizations as per the company’s specific needs. The following customization options are available for the report:

Geographical Analysis

  • Further breakdown of the in vivo toxicology market into Europe, APAC , and LATAM countries

Company Information

  • Detailed analysis and profiling of additional market players (Up to 5)

Table of Contents

1 Introduction (Page No. - 15)
    1.1 Objectives of the Study
    1.2 Definition
    1.3 Market Scope
           1.3.1 Markets Covered
    1.4 Years Considered for the Study
    1.5 Currency
    1.6 Limitations
    1.7 Stakeholders

2 Research Methodology (Page No. - 18)
    2.1 Research Data
    2.2 Market Ranking
           2.2.1 Secondary Data
                    2.2.1.1 Secondary Sources
           2.2.2 Primary Data
                    2.2.2.1 Key Data From Primary Sources
                    2.2.2.2 Key Industry Insights
    2.3 Market Size Estimation
           2.3.1 Bottom-Up Approach
           2.3.2 Top-Down Approach
    2.4 Market Breakdown and Data Triangulation
    2.5 Assumptions

3 Executive Summary (Page No. - 27)

4 Premium Insights (Page No. - 31)
    4.1 Attractive Opportunities in the In Vivo Toxicology Market
    4.2 Global Market, By Testing Type
    4.3 Europe: Market, By Toxicity Endpoint and By Country/Region
    4.4 Global Market: Developing vs Developed Countries
    4.5 Global In Vivo Toxicology Market: Geographic Snapshot

5 Market Overview (Page No. - 34)
    5.1 Introduction
    5.2 Market Dynamics
           5.2.1 Drivers
                    5.2.1.1 Increasing Pharmaceutical R&D Activities
                    5.2.1.2 Mandatory Government Regulations for Animal Testing
                    5.2.1.3 Innovations in Animal Models
                    5.2.1.4 Exclusive In Vivo Toxicology Tests
           5.2.2 Restraints
                    5.2.2.1 Alternative Methods to Animal Testing
                    5.2.2.2 Disadvantages Associated With Animal Toxicology Testing
           5.2.3 Opportunities
                    5.2.3.1 Increasing Research in Oncology and Personalized Medicine
                    5.2.3.2 Rising Demand for Humanized Animal Models
           5.2.4 Challenges
                    5.2.4.1 Regulations and Laws for the Ethical Use of Animals in Research

6 In Vivo Toxicology Market, By Product (Page No. - 41)
    6.1 Introduction
    6.2 Consumables
           6.2.1 Reagents & Kits
           6.2.2 Animal Models
                    6.2.2.1 Mice Models
                    6.2.2.2 Rat Models
                    6.2.2.3 Other Animal Models
    6.3 Instruments

7 In Vivo Toxicology Market, By Testing Type (Page No. - 53)
    7.1 Introduction
    7.2 Chronic Toxicity Testing
    7.3 Sub-Chronic Toxicity Testing
    7.4 Sub-Acute Toxicity Testing
    7.5 Acute Toxicity Testing

8 In Vivo Toxicology Market, By Toxicity Endpoint (Page No. - 60)
    8.1 Introduction
    8.2 Immunotoxicity
    8.3 Systemic Toxicity
    8.4 Carcinogenicity
    8.5 Genotoxicity
    8.6 Developmental and Reproductive Toxicity (DART)
    8.7 Other Toxicity Endpoints

9 In Vivo Toxicology Market, By Testing Facility (Page No. - 70)
    9.1 Introduction
    9.2 Outsourced Testing Facilities
    9.3 In-House Testing Facilities

10 In Vivo Toxicology Market, By Region (Page No. - 76)
     10.1 Introduction
     10.2 North America
             10.2.1 US
             10.2.2 Canada
     10.3 Europe
             10.3.1 Germany
             10.3.2 UK
             10.3.3 France
             10.3.4 Rest of Europe (RoE)
     10.4 Asia Pacific
             10.4.1 Japan
             10.4.2 China
             10.4.3 India
             10.4.4 Rest of Asia Pacific
     10.5 Latin America
     10.6 Middle East & Africa

11 Competitive Landscape (Page No. - 138)
     11.1 Overview
     11.2 Ranking of Players
     11.3 Market Share Analysis
     11.4 Competitive Scenario
             11.4.1 Product & Service Launches
             11.4.2 Collaborations, Partnerships, and Agreements
             11.4.3 Acquisitions and Mergers
             11.4.4 Expansions
             11.4.5 Other Developments

12 Company Profiles (Page No. - 145)
(Business Overview, Products Offered, Recent Developments, SWOT Analysis, MnM View)*
     12.1 Thermo Fisher Scientific
     12.2 Danaher
     12.3 Charles River Laboratories
     12.4 Labcorp
     12.5 The Jackson Laboratory
     12.6 Data Sciences International
     12.7 Envigo
     12.8 Eurofins Scientific
     12.9 Perkinelmer
     12.10 SRI International
     12.11 Taconic Biosciences
     12.12 Wuxi Apptec

*Business Overview, Products Offered, Recent Developments, SWOT Analysis, MnM View Might Not Be Captured in Case of Unlisted Companies.

13 Appendix (Page No. - 187)
     13.1 Insights of Industry Experts
     13.2 Discussion Guide
     13.3 Knowledge Store: Marketsandmarkets’ Subscription Portal
     13.4 Introducing RT: Real-Time Market Intelligence
     13.5 Related Reports
     13.6 Author Details


List of Tables (124 Tables)

Table 1 Innovative Animal Models Developed and Launched By Players
Table 2 Regulatory Authorities Overseeing the Use of Animal Models in Research
Table 3 In Vivo Toxicology Market, By Product, 2015–2022 (USD Million)
Table 4 In Vivo Toxicology Consumables Market, By Segment, 2015–2022 (USD Million)
Table 5 In Vivo Toxicology Consumables Market, By Country, 2015–2022 (USD Million)
Table 6 Reagents & Kits Market, By Country, 2015–2022 (USD Million)
Table 7 Animal Models Market, By Type, 2015–2022 (USD Million)
Table 8 Animal Models Market, By Country, 2015–2022 (USD Million)
Table 9 Mice Models Market, By Country, 2015–2022 (USD Million)
Table 10 Rat Models Market, By Country, 2015–2022 (USD Million)
Table 11 Other Animal Models Market, By Country, 2015–2022 (USD Million)
Table 12 In Vivo Toxicology Instruments Market, By Country, 2015–2022 (USD Million)
Table 13 In Vivo Toxicology Market, By Type, 2015–2022 (USD Million)
Table 14 Chronic Toxicity Testing Market, By Country, 2015–2022 (USD Million)
Table 15 Sub-Chronic Toxicity Testing Market, By Country, 2015–2022 (USD Million)
Table 16 Sub-Acute Toxicity Testing Market, By Country, 2015–2022 (USD Million)
Table 17 Acute Toxicity Testing Market, By Country, 2015–2022 (USD Million)
Table 18 Global Market, By Toxicity Endpoint, 2015–2022 (USD Million)
Table 19 Global Market for Immunotoxicity, By Country, 2015–2022 (USD Million)
Table 20 Global Market for Systemic Toxicity, By Country, 2015–2022 (USD Million)
Table 21 Global Market for Carcinogenicity, By Country, 2015–2022 (USD Million)
Table 22 Global Market for Genotoxicity, By Country, 2015–2022 (USD Million)
Table 23 Global Market for Developmental and Reproductive Toxicity, By Country, 2015–2022 (USD Million)
Table 24 In Vivo Toxicology Market for Other Toxicity Endpoints, By Country, 2015–2022 (USD Million)
Table 25 Global Market, By Testing Facility, 2015–2022 (USD Million)
Table 26 Global Market for Outsourced Testing Facilities, By Country, 2015–2022 (USD Million)
Table 27 Global Market for In-House Testing Facilities, By Country, 2015–2022 (USD Million)
Table 28 Global Market, By Country/Region, 2015–2022 (USD Million)
Table 29 North America: In Vivo Toxicology Market, By Country, 2015–2022 (USD Million)
Table 30 North America: Market, By Product, 2015–2022 (USD Million)
Table 31 North America: In Vivo Toxicology Consumables Market, By Segment, 2015–2022 (USD Million)
Table 32 North America: Market for Animal Models, By Type, 2015–2022 (USD Million)
Table 33 North America: Market, By Testing Type, 2015–2022 (USD Million)
Table 34 North America: Market, By Toxicity Endpoint, 2015–2022 (USD Million)
Table 35 North America: Market, By Testing Facility, 2015–2022 (USD Million)
Table 36 Nih Funding for Projects Related to Animal Models
Table 37 US: In Vivo Toxicology Market, By Product, 2015–2022 (USD Million)
Table 38 US: In Vivo Toxicology Consumables Market, By Segment, 2015–2022 (USD Million)
Table 39 US: Market for Animal Models, By Type, 2015–2022 (USD Million)
Table 40 US: Market, By Testing Type, 2015–2022 (USD Million)
Table 41 US: Market, By Toxicity Endpoint, 2015–2022 (USD Million)
Table 42 US: Market, By Testing Facility, 2015–2022 (USD Million)
Table 43 Canada: In Vivo Toxicology Market, By Product, 2015–2022 (USD Million)
Table 44 Canada: In Vivo Toxicology Consumables Market, By Segment, 2015–2022 (USD Million)
Table 45 Canada: Market for Animal Models, By Type, 2015–2022 (USD Million)
Table 46 Canada: Market, By Testing Type, 2015–2022 (USD Million)
Table 47 Canada: Market, By Toxicity Endpoint, 2015–2022 (USD Million)
Table 48 Canada: Market, By Testing Facility, 2015–2022 (USD Million)
Table 49 Europe: In Vivo Toxicology Market, By Country, 2015–2022 (USD Million)
Table 50 Europe: Market, By Product, 2015–2022 (USD Million)
Table 51 Europe: In Vivo Toxicology Consumables Market, By Segment, 2015–2022 (USD Million)
Table 52 Europe: Market for Animal Models, By Type, 2015–2022 (USD Million)
Table 53 Europe: Market, By Testing Type, 2015–2022 (USD Million)
Table 54 Europe: Market, By Toxicity Endpoint, 2015–2022 (USD Million)
Table 55 Europe: Market, By Testing Facility, 2015–2022 (USD Million)
Table 56 Germany: In Vivo Toxicology Market, By Product, 2015–2022 (USD Million)
Table 57 Germany: In Vivo Toxicology Consumables Market, By Segment, 2015–2022 (USD Million)
Table 58 Germany: Market for Animal Models, By Type, 2015–2022 (USD Million)
Table 59 Germany: Market, By Testing Type, 2015–2022 (USD Million)
Table 60 Germany: Market, By Toxicity Endpoint, 2015–2022 (USD Million)
Table 61 Germany: Market, By Testing Facility, 2015–2022 (USD Million)
Table 62 UK: In Vivo Toxicology Market, By Product, 2015–2022 (USD Million)
Table 63 UK: In Vivo Toxicology Consumables Market, By Segment, 2015–2022 (USD Million)
Table 64 UK: Market for Animal Models, By Type, 2015–2022 (USD Million)
Table 65 UK: Market, By Testing Type, 2015–2022 (USD Million)
Table 66 UK: Market, By Toxicity Endpoint, 2015–2022 (USD Million)
Table 67 UK: Market, By Testing Facility, 2015–2022 (USD Million)
Table 68 France: In Vivo Toxicology Market, By Product, 2015–2022 (USD Million)
Table 69 France: In Vivo Toxicology Consumables Market, By Segment, 2015–2022 (USD Million)
Table 70 France: Market for Animal Models, By Type, 2015–2022 (USD Million)
Table 71 France: Market, By Testing Type, 2015–2022 (USD Million)
Table 72 France: Market, By Toxicity Endpoint, 2015–2022 (USD Million)
Table 73 France: Market, By Testing Facility, 2015–2022 (USD Million)
Table 74 RoE: In Vivo Toxicology Market, By Product, 2015–2022 (USD Million)
Table 75 RoE: In Vivo Toxicology Consumables Market, By Segment, 2015–2022 (USD Million)
Table 76 RoE: Market for Animal Models, By Type, 2015–2022 (USD Million)
Table 77 RoE: Market, By Testing Type, 2015–2022 (USD Million)
Table 78 RoE: Market, By Toxicity Endpoint, 2015–2022 (USD Million)
Table 79 RoE: Market, By Testing Facility, 2015–2022 (USD Million)
Table 80 APAC: In Vivo Toxicology Market, By Country/Region, 2015–2022 (USD Million)
Table 81 APAC: Market, By Product, 2015–2022 (USD Million)
Table 82 APAC: In Vivo Toxicology Consumables Market, By Segment, 2015–2022 (USD Million)
Table 83 APAC: Market for Animal Models, By Type, 2015–2022 (USD Million)
Table 84 APAC: Market, By Testing Type, 2015–2022 (USD Million)
Table 85 APAC: Market, By Toxicity Endpoint, 2015–2022 (USD Million)
Table 86 APAC: Market, By Testing Facility, 2015–2022 (USD Million)
Table 87 Research Collaborations By Foreign-Affiliated Companies and Japanese Universities/Research Institutes (2016)
Table 88 Japan: In Vivo Toxicology Market, By Product, 2015–2022 (USD Million)
Table 89 Japan: In Vivo Toxicology Consumables Market, By Segment, 2015–2022 (USD Million)
Table 90 Japan: Market for Animal Models, By Type, 2015–2022 (USD Million)
Table 91 Japan: Market, By Testing Type, 2015–2022 (USD Million)
Table 92 Japan: Market, By Toxicity Endpoint, 2015–2022 (USD Million)
Table 93 Japan: Market, By Testing Facility, 2015–2022 (USD Million)
Table 94 China: In Vivo Toxicology Market, By Product, 2015–2022 (USD Million)
Table 95 China: In Vivo Toxicology Consumables Market, By Segment, 2015–2022 (USD Million)
Table 96 China: Market for Animal Models, By Type, 2015–2022 (USD Million)
Table 97 China: Market, By Testing Type, 2015–2022 (USD Million)
Table 98 China: Market, By Toxicity Endpoint, 2015–2022 (USD Million)
Table 99 China: Market, By Testing Facility, 2015–2022 (USD Million)
Table 100 India: In Vivo Toxicology Market, By Product, 2015–2022 (USD Million)
Table 101 India: In Vivo Toxicology Consumables Market, By Segment, 2015–2022 (USD Million)
Table 102 India: Market for Animal Models, By Type, 2015–2022 (USD Million)
Table 103 India: Market, By Testing Type, 2015–2022 (USD Million)
Table 104 India: Market, By Toxicity Endpoint, 2015–2022 (USD Million)
Table 105 India: Market, By Testing Facility, 2015–2022 (USD Million)
Table 106 RoAPAC: In Vivo Toxicology Market, By Product, 2015–2022 (USD Million)
Table 107 RoAPAC: In Vivo Toxicology Consumables Market, By Segment, 2015–2022 (USD Million)
Table 108 RoAPAC: Market for Animal Models, By Type, 2015–2022 (USD Million)
Table 109 RoAPAC: Market, By Testing Type, 2015–2022 (USD Million)
Table 110 RoAPAC: Market, By Toxicity Endpoint, 2015–2022 (USD Million)
Table 111 RoAPAC: Market, By Testing Facility, 2015–2022 (USD Million)
Table 112 Latin America: In Vivo Toxicology Market, By Product, 2015–2022 (USD Million)
Table 113 Latin America: In Vivo Toxicology Consumables Market, By Segment, 2015–2022 (USD Million)
Table 114 Latin America: Market for Animal Models, By Type, 2015–2022 (USD Million)
Table 115 Latin America: Market, By Testing Type, 2015–2022 (USD Million)
Table 116 Latin America: Market, By Toxicity Endpoint, 2015–2022 (USD Million)
Table 117 Latin America: Market, By Testing Facility, 2015–2022 (USD Million)
Table 118 Middle East & Africa: In Vivo Toxicology Market, By Product, 2015–2022 (USD Million)
Table 119 Middle East & Africa: In Vivo Toxicology Consumables Market, By Segment, 2015–2022 (USD Million)
Table 120 Middle East & Africa: Market for Animal Models, By Type, 2015–2022 (USD Million)
Table 121 Middle East & Africa: Market, By Testing Type, 2015–2022 (USD Million)
Table 122 Middle East & Africa: Market, By Toxicity Endpoint, 2015–2022 (USD Million)
Table 123 Middle East & Africa: Market, By Testing Facility, 2015–2022 (USD Million)
Table 124 Rank of Companies in the Global Market, By Instruments, 2017


List of Figures (38 Figures)

Figure 1 Research Design
Figure 2 Breakdown of Primary Interviews: By Company Size, Designation, and Region
Figure 3 Market Data Triangulation Methodology
Figure 4 In Vivo Toxicology Market, By Product, 2017 vs 2022 (USD Billion)
Figure 5 Global Market, By Testing Type, 2017 vs 2022 (USD Billion)
Figure 6 Global Market, By Toxicity Endpoint, 2017 vs 2022 (USD Billion)
Figure 7 Global Market, By Testing Facility, 2017 vs 2022 (USD Billion)
Figure 8 Geographical Snapshot of the Global Market
Figure 9 Increasing Pharmaceutical R&D Activities and Mandatory Government Regulations for Animal Testing to Drive Market Growth
Figure 10 Chronic Testing Segment to Command the Largest Share in the Market in 2017
Figure 11 Immunotoxicity Segment to Command the Largest Share in the European Market in 2017
Figure 12 Developing Countries to Grow at the Highest Rate From 2017 to 2022
Figure 13 China to Register Highest Growth During the Forecast Period
Figure 14 In Vivo Toxicology Market: Drivers, Restraints, Opportunities, and Challenges
Figure 15 Pharmaceutical R&D Expenditure in the Us, Europe, and Japan (2000—2015)
Figure 16 Consumables Segment Will Continue to Dominate the Global Market During the Forecast Period
Figure 17 Chronic Toxicity Testing Segment Will Continue to Dominate the Global Market in 2022
Figure 18 Immunotoxicity Segment Will Continue to Dominate the Global Market in 2022
Figure 19 Outsourced Testing Facilities Will Continue to Dominate the In Vivo Toxicology Market in 2022
Figure 20 Global Market: Geographic Growth Opportunities
Figure 21 North America: Market Snapshot
Figure 22 Europe: Market Snapshot
Figure 23 Number of Cell Therapy Preclinical Studies in the UK (2013–2016)
Figure 24 RoE Countries: Pharmaceutical Industry R&D Expenditure (2015)
Figure 25 APAC: Market Snapshot
Figure 26 India: R&D Spending By Top Pharma Giants in Fy 2016
Figure 27 Latam: Market Snapshot
Figure 28 Companies Adopted Product & Service Launches as Their Key Growth Strategy Over the Last Three Years
Figure 29 Global Animal Models Market Share, By Key Player, 2016
Figure 30 Global In Vivo Toxicology Services (CRO) Market Share, By Key Player, 2016
Figure 31 Thermo Fisher Scientific: Company Snapshot
Figure 32 Danaher: Company Snapshot
Figure 33 Charles River Laboratories: Company Snapshot
Figure 34 Labcorp: Company Snapshot
Figure 35 The Jackson Laboratory: Company Snapshot
Figure 36 Envigo: Company Snapshot
Figure 37 Eurofins Scientific: Company Snapshot
Figure 38 Perkinelmer: Company Snapshot

The global in vivo toxicology market is projected to reach USD 6.14 Billion by 2022 from USD 4.40 Billion in 2017, at a CAGR of 6.9%. Some key factors driving market growth are the increasing pharmaceutical R&D activities, mandatory government regulations for animal testing, innovations in animal models, and the development of exclusive in vivo toxicology tests. Factors such as increasing research in oncology and personalized medicine and the rising demand for humanized animal models are expected to offer lucrative opportunities for players in the global market.

In this report, the global in vivo toxicology market is segmented by product, testing type, toxicity endpoint, testing facility, and region. Based on product, the global market is segmented into consumables and instruments. The consumables segment is further divided into reagents & kits and animal models (including mice model, rat model, and other animal models). In 2017, the consumables segment is expected to account for the largest share of the global market. The large share of this segment is attributed to the increasing R&D funding for the development of new transgenic animal models, advancements in the development of genetically modified animals, and increasing pharmaceutical research for developing new drug molecules.

Based on testing type, the in vivo toxicology market is segmented into chronic, sub-chronic, sub-acute, and acute toxicology testing. In 2017, the chronic toxicity testing segment is expected to account for the largest share of the global market. Increasing research focused on drugs used for long-duration therapies such as anti-cancer, anti-convulsive, anti-arthritis, and anti-hypertensives is driving the growth of the chronic toxicity testing market. However, the sub-acute toxicity testing segment is expected to register the highest CAGR of during the forecast period.

By toxicity endpoint, the in vivo toxicology market is segmented into immunotoxicity, systemic toxicity, carcinogenicity, genotoxicity, developmental and reproductive toxicity (DART), and other toxicity endpoints (includes organ toxicity, endocrine disruptor toxicity, juvenile toxicity, phototoxicity, ocular toxicity, and skin irritation). The immunotoxicity segment is expected to account for the largest share of the global market in 2017, followed by the systemic toxicity segment. The rising demand for the development of biologics and biosimilars is driving the growth of the immunotoxicity segment.

Based on the testing facility, the global in vivo toxicology market is segmented into outsourced testing facilities and in-house testing facilities. In 2017, the outsourced testing facilities segment is expected to account for the largest share of the global market. The large share of this segment is attributed to the increasing R&D investments and cost-saving strategies of pharmaceutical, biopharmaceutical, and medical devices companies, which in turn results in increasing outsourcing of services to CROs.

In Vivo Toxicology Market

Geographically, North America is estimated to dominate the market in 2017 with the highest market share in the in vivo toxicology market. The largest share of this regional segment is attributed to the increasing investments in R&D activities, scientific developments in biotechnology, and the presence of major pharmaceutical and preclinical testing companies in the region. However, Latin America (LATAM) is expected to grow at the highest CAGR during the forecast period. Factors such as the flourishing pharmaceutical and biopharmaceutical industry in Brazil in turn propelling the drug development activities and increase in the number of CROs that offer cost-effective in vivo toxicology services are driving the growth of the global market in LATAM.

While the overall in vivo toxicology market is expected to grow at a high rate, growing pressures to develop and conduct alternative tests for animal testing and disadvantages associated with animal testing are likely to restrain the growth of this market to a certain extent. The major players in the global market include Thermo Fisher (US), Danaher (US), Charles River (US), Covance (LabCorp), Eurofins (Luxembourg), Envigo (US), DSI (US), and The Jackson Laboratory (US).

To speak to our analyst for a discussion on the above findings, click Speak to Analyst

Custom Market Research Services

We will customize the research for you, in case the report listed above does not meet with your exact requirements. Our custom research will comprehensively cover the business information you require to help you arrive at strategic and profitable business decisions.

Please visit https://www.marketsandmarkets.com/knowledge-process-outsourcing-services.asp to specify your custom Research Requirement

Connect With Us

Follow us on LinkedIn  Follow us on Facebook   Follow us on Twitter 
Live Chat Support


US : 1-888-600-6441
UK : 44-800-368-9399

Search reports



Access reports on all high
growth Biotechnology Markets on KnowledgeStore
Request Demo